scispace - formally typeset
Search or ask a question
Institution

University of Saskatchewan

EducationSaskatoon, Saskatchewan, Canada
About: University of Saskatchewan is a education organization based out in Saskatoon, Saskatchewan, Canada. It is known for research contribution in the topics: Population & Health care. The organization has 25021 authors who have published 52579 publications receiving 1483049 citations. The organization is also known as: USask.


Papers
More filters
Journal ArticleDOI
TL;DR: It was demonstrated that very high-risk aboriginal offenders were particularly vulnerable to dropping out of treatment and the implication that treatment noncompletion may have for issues concerning risk, recidivism, and responsivity.
Abstract: This investigation examined factors contributing to attrition from correctional treatment and the implication that treatment noncompletion may have for issues concerning risk, recidivism, and respo...

213 citations

Journal ArticleDOI
TL;DR: For instance, in this paper, the average sigma PCB concentrations in polar bears from the Canadian Arctic were similar to those in 1982-84, while average Sigma CHL and DDE concentrations were 35-44% lower and DIEL was 90% lower.
Abstract: Adipose tissue samples from polar bears (Ursus maritimus) were obtained by necropsy or biopsy between the spring of 1989 to the spring of 1993 from Wrangel Island in Russia, most of the range of the bear in North America, eastern Greenland, and Svalbard. Samples were divided into 16 regions corresponding as much as possible to known stocks or management zones. Concentrations of dieldrin (DIEL), 4,4'-DDE (DDE), sum of 16 polychlorinated biphenyl congeners (sigma PCB), and sum of 11 chlordane-related compounds and metabolites (sigma CHL) were determined. In order to minimize the effect of age, only data for adults (320 bears age 5 years and older) was used to compare concentrations among regions. Concentrations of sigma PCB were 46% higher in adult males than females, and there was no significant trend with age. Concentrations of sigma CHL were 30% lower in adult males than females. Concentrations of sigma PCB, sigma CHL, and DDE in individual adult female bears were standardized to adult males using factors derived from the least-square means of each sex category, and geometric means of the standardized concentrations on a lipid weight basis were compared among regions. Median geometric mean standardized concentrations (lipid weight basis) and ranges among regions were as follows: sigma PCB, 5,942 (2,763-24,316) micrograms/kg; sigma CHL, 1,952 (727-4,632) micrograms/kg; DDE, 219 (52-560) micrograms/kg; DIEL, 157 (31-335) micrograms/kg. Geometric mean sigma PCB concentrations in bears from Svalbard, East Greenland, and the Arctic Ocean near Prince Patrick Island in Canada were similar (20,256-24,316 micrograms/kg) and significantly higher than most other areas. Atmospheric, oceanic, and ice transport, as well as ecological factors may contribute to these high concentrations of sigma PCB. sigma CHL was more uniformly distributed among regions than the other CHCs. Highest sigma CHL concentrations were found in southeastern Hudson Bay, which also had the highest DDE and DIEL concentrations. In general, concentrations of sigma CHL, DDE, and DIEL were higher in eastern than western regions, suggesting an influence of North American sources. Average sigma PCB concentrations in bears from the Canadian Arctic were similar to those in 1982-84, while average sigma CHL and DDE concentrations were 35-44% lower and DIEL was 90% lower. However, the significance of these temporal trends during the 1980s is not conclusive because of the problems of comparability of data.

213 citations

Journal ArticleDOI
TL;DR: The prevalence of meeting DRI recommendations and the role of vitamin D supplement use among Canadians aged 6-79 y are determined and it is suggested that current food choices alone are insufficient to maintain 25(OH)D concentrations of 50 nmol/L in many Canadians, especially in winter.

213 citations

Journal ArticleDOI
TL;DR: Mature DC pulsed with EXOOVA, which were referred to as mDCEXO, expressed a higher level of pMHC I, MHC II, and costimulatory CD40, CD54 and CD80 than DCOVA, and may represent a new, highly effective DC‐based vaccine for the induction of antitumour immunity.
Abstract: Exosomes (EXO) derived from dendritic cells (DC), which express major histocompatibility complex (MHC) and costimulatory molecules, have been used for antitumour vaccines. However, they are still less effective by showing only prophylatic immunity in animal models or very limited immune responses in clinical trials. In this study, we showed that ovalbumin (OVA) protein-pulsed DC (DC(OVA))-derived EXO (EXO(OVA)) displayed MHC class I-OVA I peptide (pMHC I) complexes, CD11c, CD40, CD80, CCR7, DEC205, Toll-like receptor 4 (TLR4), TLR9, MyD88 and DC-SIGN molecules, but at a lower level than DC(OVA). EXO(OVA) can be taken up by DC through LFA-1/CD54 and C-type lectin/mannose (glucosamine)-rich C-type lectin receptor (CLR) interactions. Mature DC pulsed with EXO(OVA), which were referred to as mDC(EXO), expressed a higher level of pMHC I, MHC II, and costimulatory CD40, CD54 and CD80 than DC(OVA). The mDC(EXO) could more strongly stimulate OVA-specific CD8(+) T-cell proliferation in vitro and in vivo, and more efficiently induce OVA-specific cytotoxic T-lymphocyte responses, antitumour immunity and CD8(+) T-cell memory in vivo than EXO(OVA) and DC(OVA). In addition, mDC(EXO) could also more efficiently eradicate established tumours. Therefore, mature DC pulsed with EXO may represent a new, highly effective DC-based vaccine for the induction of antitumour immunity.

213 citations

Journal ArticleDOI
TL;DR: An international study group to discuss the nature of refractoriness to antipsychotic drug therapy exhibited by a substantial minority of schizophrenic patients and the role of psychosocial and drug therapies in increasing the responsiveness of the treatment refractory patient is distillation of their efforts.
Abstract: Addressing the need for research on the nature of refractoriness to antipsychotic drug therapy exhibited by a substantial minority of schizophrenic patients, Philip R.A. May and Sven Jonas Dencker instigated an international study group to discuss this problem, beginning with the International Congress of Neuropsychopharmacology in Goteborg, Sweden, in 1980. The study group subsequently met in Haar, Federal Republic of Germany, in 1985; in Banff, Canada, in 1986; and again in Telfs, Austria, in 1988. The study group set three objectives: (1) to clarify the concept of treatment resistance or refractoriness; (2) to suggest criteria for defining or rating the degree of treatment refractoriness; and (3) to explore the role of psychosocial and drug therapies in increasing the responsiveness of the treatment refractory patient. This position article represents a distillation of the study group's efforts to define treatment refractoriness in schizophrenia.

213 citations


Authors

Showing all 25277 results

NameH-indexPapersCitations
Tomas Hökfelt158103395979
Frederick Wolfe119417101272
Christopher G. Goetz11665159510
John P. Giesy114116262790
Helmut Kettenmann10438040211
Paul M. O'Byrne10460556520
Susan S. Taylor10451842108
Keith A. Hobson10365341300
Mark S. Tremblay10054143843
James F. Fries10036983589
Gordon McKay9766161390
Jonathan D. Adachi9658931641
Wenjun Zhang9697638530
William C. Dement9634043014
Chris Ryan9597134388
Network Information
Related Institutions (5)
University of British Columbia
209.6K papers, 9.2M citations

95% related

McGill University
162.5K papers, 6.9M citations

94% related

University of Toronto
294.9K papers, 13.5M citations

94% related

University of California, Davis
180K papers, 8M citations

92% related

Cornell University
235.5K papers, 12.2M citations

91% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
2023173
2022350
20213,129
20202,913
20192,665
20182,479